<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Doug Devens

20 years of diverse medical device experience, including leading companies 3M, Coloplast and Boston Scientific, along with emerging companies. Leadership experience in product development, including championing the process for voice of customer and concept feedback sessions with key thought leaders.
Find me on:

Recent Posts

Q318 Market Recap: US Surgical Matrices

Posted by Doug Devens on 1/8/19 9:30 AM

The US Surgical Matrices Market continued to advance in Q318, up +10.3% YoY, fueled by continued rapid adoption of allograft breast matrices and the resurgence of synthetic hernia matrices.

According to BioMedGPS’  SmartTRAK Financial Dashboard, in Q318, the US Surgical Matrices Market grew +10.3% YoY. The allograft breast matrices and biosynthetic hernia matrices segments outpaced overall market growth, as both posted...

Among the many interesting topics covered in the Q318 US Surgical Matrices Market Recap are:

Read More

Topics: Surgical Matrices, Q318 Market Recaps

Q318 US Hemostats and Sealants Market Recap

Posted by Doug Devens on 1/3/19 12:00 PM

The US market for Hemostats and Sealants accelerated substantially in Q318 vs Q218

As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the Hemostats and Sealants market, with the exception of Pfizer, saw revenue growth in Q318. Leading the way were Baxter, with its integration of the Mallinckrodt portfolio, as well as Ethicon and Integra, while Pfizer posted...

Among the many topics covered in the Q318 US Hemostats and Sealants Market Recap are:

Read More

Topics: Q318 Market Recaps, Biosurgery-Hemostats and Sealants

Top Trends in the Hemostats and Sealants Market

Posted by Doug Devens on 11/5/18 9:00 AM

The Hemostats and Sealants Market continues to grow at a steady clip. SmartTRAK projects this market will reach more than $3.5B by 2022E with a five-year CAGR of ~5%.

It’s good news for many, but do you know the real story behind those numbers?

SmartTRAK identifies what’s driving growth in the global Hemostats and Sealants market. In this Market Outlook article, Doug Devens, SmartTRAK's Senior Analyst, Biosurgery, does a deep dive, discussing what’s fueling this growth and reviews the top market trends you need to know for the year ahead.

  • Trend #1: Expanding Indications Fuel Increased Adoption of Fibrin Sealants
  • Trend #2: Increasing Use of Sealant Patch Products
  • Trend #3: New Plant-Based Technologies Gaining Ground
  • Trend #4: Biologic Sealants Ready for Bounce Back

DownloadMarket Outlook: Top Trends to Watch in Hemostats and Sealants

Read More

Topics: Biosurgery-Hemostats and Sealants

SmartTRAK Attending Clinical Congress 2018 - American College of Surgeons

Posted by Doug Devens on 10/15/18 10:40 AM

SmartTRAK is excited to be attending ACS - the 2018 Clinical Congress of the American College of Surgeons - on October 21-25 in Boston, Mass. 

Doug Devens, Senior Analyst, Biosurgery and Geoffrey Brown, Director Corporate Accounts, Wound Care will be representing SmartTRAK at the conference. Please  contact us if you would like schedule a meeting at ASC to see what SmartTRAK can do for you.
Read More

Topics: SmartTRAK Conferences

Q218 US Surgical Matrices Market Recap

Posted by Doug Devens on 9/24/18 9:00 AM

The US Surgical Matrices Market advanced again in Q218

In Q218, the US Surgical Matrices Market grew +9.5% YoY according to BioMedGPS’ SmartTRAK Financial Dashboard. The allograft breast matrices and biosynthetic hernia matrices segments outpaced overall market growth, as both posted strong growth in Q218...

Among the many topics covered in the Q218 US Surgical Matrices Recap are:

Read More

Topics: Advanced Wound Care-Surgical Matrices

Q218 US Hemostats and Sealants Market Recap: Revenue Grows

Posted by Doug Devens on 8/29/18 12:04 PM

Baxter, Ethicon and Integra lead the way...

As reported in  SmartTRAK’s Financial Dashboard, the US market for Hemostats and Sealants grew +3.8% YoY in Q218, an increase from +3.1% growth rate overall in Q118. Fibrin sealants continue to lead the way with +7.2% YoY growth in Q218, and thrombin hemostats had a very good quarter with +7.2% growth YoY...

Among the many topics covered in the full Q218 Hemostats and Sealants Market Recap are:

  • Ethicon Continues to Lead Hemostats and Sealants
  • Thrombins Come Back In Hemostats
  • Fibrin Continues To Shine In Sealants
  • Q218 events in the US Hemostats and Sealants Market
Read More

Topics: Biosurgery-Hemostats and Sealants

SmartTRAK Publication Alert: Q118 Hemostats and Sealants Market Recap

Posted by Doug Devens on 6/13/18 9:00 AM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Hemostats and Sealants Market Recap.

Read More

Topics: Biosurgery-Hemostats and Sealants

SmartTRAK Publication Alert: Q118 Surgical Matrices Market Recap

Posted by Doug Devens on 6/11/18 6:16 PM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 US Surgical Matrices Market Recap.

Read More

Topics: Wound Care-Surgical Matrices

SmartTRAK's Final 2017 US Surgical Matrices Market Financial Results

Posted by Doug Devens on 4/4/18 10:27 AM

The US Surgical Matrices Market advanced again in Q417, reaching sales of $338.2MM, up +6.8% YoY, fueled by double-digit growth in allograft breast matrices and biosynthetics hernia matrices.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Surgical Matrices Market Recap and Financial Dashboard.

Among the many topics covered in the Q417/FY17 US Surgical Matrices Market Recap are:

Read More

Topics: Wound Care-Surgical Matrices

SmartTRAK's Final 2017 Hemostats & Sealants Market Financial Results

Posted by Doug Devens on 3/22/18 4:39 PM

The US market for Hemostats and Sealants recovered in Q417, up +5.0% YoY, in line with historic growth rates. While biologic sealants continue to lag, every other segment grew, led by absorbable hemostats and fibrin sealants.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 Hemostats & Sealants Market Recap and Financial Dashboard.

As reported in SmartTRAK’s Financial Dashboard, almost every manufacturer competing in the Hemostats and Sealants market saw revenue growth in Q417/FY17, led by BaxterEthicon and Cryolife in Q417 and by Baxter and Integra for FY17 ...

Read More

Topics: Biosurgery-Hemostats and Sealants

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts